{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:29:49Z","timestamp":1753892989421,"version":"3.41.2"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>As China amends its \u201czero COVID\u201d strategy, a sudden increase in the number of infections may overwhelm medical resources and its impact has not been quantified. Specific mitigation strategies are needed to minimize disruption to the healthcare system and to prepare for the next possible epidemic in advance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>We develop a stochastic compartmental model to project the burden on the medical system (that is, the number of fever clinic visits and admission beds) of China after adjustment to COVID-19 policy, which considers the epidemiological characteristics of the Omicron variant, age composition of the population, and vaccine effectiveness against infection and severe COVD-19. We also estimate the effect of four-dose vaccinations (heterologous and homologous), antipyretic drug supply, non-pharmacological interventions (NPIs), and triage treatment on mitigating the domestic infection peak.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>As to the impact on the medical system, this epidemic is projected to result in 398.02 million fever clinic visits and 16.58 million hospitalizations, and the disruption period on the healthcare system is 18 and 30 days, respectively. Antipyretic drug supply and booster vaccination could reduce the burden on emergency visits and hospitalization, respectively, while neither of them could not reduce to the current capacity. The synergy of several different strategies suggests that increasing the heterologous booster vaccination rate for older adult to over 90% is a key measure to alleviate the bed burden for respiratory diseases on the basis of expanded healthcare resource allocation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The Omicron epidemic followed the adjustment to COVID-19 policy overloading many local health systems across the country at the end of 2022. The combined effect of vaccination, antipyretic drug supply, triage treatment, and PHSMs could prevent overwhelming medical resources.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1259084","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T17:58:24Z","timestamp":1701539904000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Temporary impact on medical system and effectiveness of mitigation strategies after COVID-19 policy adjustment in China: a modeling study"],"prefix":"10.3389","volume":"11","author":[{"given":"Chitin","family":"Hon","sequence":"first","affiliation":[]},{"given":"Jingyi","family":"Liang","sequence":"additional","affiliation":[]},{"given":"Ruihan","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Zhijie","family":"Lin","sequence":"additional","affiliation":[]},{"given":"Yangqianxi","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[]},{"given":"Ruibin","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Jiaxi","family":"Sun","sequence":"additional","affiliation":[]},{"given":"Qianyin","family":"Li","sequence":"additional","affiliation":[]},{"given":"Lixi","family":"Liang","sequence":"additional","affiliation":[]},{"given":"Minyi","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Zichen","family":"Chang","sequence":"additional","affiliation":[]},{"given":"Yinqiu","family":"Guo","sequence":"additional","affiliation":[]},{"given":"Wenting","family":"Zeng","sequence":"additional","affiliation":[]},{"given":"Tie","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Arlindo L.","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e2282","DOI":"10.1002\/rmv.2282","article-title":"An overview on the seven pathogenic human coronaviruses","volume":"32","author":"Kesheh","year":"2022","journal-title":"Rev Med Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"113889","DOI":"10.1016\/j.biopha.2022.113889","article-title":"The role of SARS-CoV-2 accessory proteins in immune evasion","volume":"156","author":"Zandi","year":"2022","journal-title":"Biomed Pharmacother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41577-022-00715-2","article-title":"ORF9c and ORF10 as accessory proteins of SARS-CoV-2 in immune evasion","volume":"22","author":"Zandi","year":"2022","journal-title":"Nat Rev Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"nwac054","DOI":"10.1093\/nsr\/nwac054","article-title":"Strategies for reopening in the forthcoming COVID-19 era in China","volume":"9","author":"Guan","year":"2022","journal-title":"Natl Sci Rev"},{"key":"B5","unstructured":""},{"key":"B6","unstructured":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S1473-3099(23)00051-8","article-title":"Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB15 variant","volume":"23","author":"Uriu","year":"2023","journal-title":"Lancet Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1101\/2023.04.06.535883","article-title":"Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant","volume":"6","author":"Yamasoba","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.7326\/M21-1213","article-title":"Association between caseload surge and COVID-19 survival in 558 U.S. Hospitals, March to August 2020","volume":"174","author":"Kadri","year":"2021","journal-title":"Ann Intern Med"},{"key":"B10","unstructured":""},{"key":"B11","unstructured":"Phoenix TV"},{"key":"B12","unstructured":"Centre for Disease Control and Prevention of America"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e232598","DOI":"10.1001\/jamanetworkopen.2023.2598","article-title":"Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during omicron BA4 and BA5 sublineage periods","volume":"6","author":"Link-Gelles","year":"2023","journal-title":"JAMA Netw Open."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.1016\/j.vaccine.2023.07.043","article-title":"Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study","volume":"41","author":"Moscara","year":"2023","journal-title":"Vaccine."},{"key":"B15","unstructured":"2022"},{"key":"B16","unstructured":""},{"key":"B17","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1080\/22221751.2022.2088406","article-title":"Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial","volume":"11","author":"Wang","year":"2022","journal-title":"Emerg Microbes Infect."},{"key":"B18","unstructured":""},{"key":"B19","doi-asserted-by":"publisher","first-page":"100486","DOI":"10.1016\/j.lanwpc.2022.100486","article-title":"Utility of SARS-CoV-2 rapid antigen testing for patient triage in the emergency department: a clinical implementation study in Melbourne, Australia","volume":"25","author":"Bond","year":"2022","journal-title":"Lancet Reg Health West Pac."},{"key":"B20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-2923-3","article-title":"Mobility network models of COVID-19 explain inequities and inform reopening","volume":"589","author":"Chang","year":"2021","journal-title":"Nature."},{"key":"B21","doi-asserted-by":"publisher","first-page":"21256","DOI":"10.1038\/s41598-020-77628-4","article-title":"Management strategies in a SEIR-type model of COVID 19 community spread","volume":"10","author":"Radulescu","year":"2020","journal-title":"Sci Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.21037\/jtd.2020.02.64","article-title":"Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions","volume":"12","author":"Yang","year":"2020","journal-title":"J Thorac Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"100607","DOI":"10.1016\/j.lana.2023.100607","article-title":"Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study","volume":"27","author":"Gonz\u00e1lez","year":"2023","journal-title":"Lancet Reg Health Am."},{"key":"B24","doi-asserted-by":"publisher","first-page":"n2015","DOI":"10.1136\/bmj.n2015","article-title":"Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study","volume":"374","author":"Ranzani","year":"2021","journal-title":"BMJ."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e798","DOI":"10.1016\/S2214-109X(22)00112-7","article-title":"Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study","volume":"10","author":"Jara","year":"2022","journal-title":"Lancet Glob Health."},{"key":"B26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/aje\/kwh255","article-title":"Teunis Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures","volume":"160","author":"Wallinga","year":"2004","journal-title":"Am J Epidemiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1101\/2022.12.14.22283460","article-title":"Modelling the adjustment of COVID-19 response and exit from dynamic zero-COVID in China","author":"Leung","year":"2022","journal-title":"medRxiv"},{"key":"B28","unstructured":"National Health Commission of the People's Republic of China"},{"key":"B29","unstructured":"National Health Commission of the People's Republic of China"},{"key":"B30","unstructured":"National Health Commission of the People's Republic of China"},{"key":"B31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41591-023-02648-2","article-title":"Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population","volume":"29","author":"Lau","year":"2023","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jinf.2023.01.029","article-title":"Infection rates of 70% of the population observed within 3 weeks after release of COVID-19 restrictions in Macao, China","volume":"86","author":"Liang","year":"2023","journal-title":"J Infect."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2254777","DOI":"10.1001\/jamanetworkopen.2022.54777","article-title":"Estimation of vaccine effectiveness of CoronaVac and BNT162b2 against severe outcomes over time among patients with SARS-CoV-2 omicron","volume":"6","author":"Wei","year":"2023","journal-title":"JAMA Netw Open."},{"key":"B34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.7748\/ns.2021.e11690","article-title":"Moving from face-to-face to telephone assessments with patients during the COVID-19 pandemic","volume":"36","author":"Burgess","year":"2021","journal-title":"Nurs Stand."},{"year":"","key":"B35"},{"key":"B36","doi-asserted-by":"publisher","first-page":"965971","DOI":"10.3389\/fimmu.2022.965971","article-title":"Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"100198","DOI":"10.1016\/j.lana.2022.100198","article-title":"Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: a retrospective cohort study","volume":"9","author":"Tartof","year":"2022","journal-title":"Lancet Reg Health Am."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.3390\/jcm11113074","article-title":"Comparison of three different waves in healthcare workers during the COVID-19 pandemic: a retrospective observational study in an Italian University Hospital","volume":"11","author":"De Maria","year":"2022","journal-title":"J Clin Med"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1259084\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T17:58:28Z","timestamp":1701539908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1259084\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":38,"alternative-id":["10.3389\/fpubh.2023.1259084"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1259084","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"article-number":"1259084"}}